Immunotherapy for glioblastoma: going viral.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 30082860.
- Also identified by DOI 10.1038/s41591-018-0142-3 and PMC identifier 6443579.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intratumoral infusion of a nonpathogenic replication-competent recombinant polio-rhinovirus chimera for recurrent glioblastoma demonstrates safety and promising preliminary treatment responses.
Medical subject headings
- Glioblastoma
- Immunotherapy
- Oncolytic Virotherapy